$2.71
-0.04-1.44%
Pre-Market: 5:36 PM EDT
15 minutes delayed
AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.13 | $-0.14 | 7.14 % |
Mar 2024 | 2024-05-07 | $-0.14 | $-0.17 | 17.6 % |
Dec 2023 | 2024-02-20 | $-0.16 | $-0.13 | -23.1 % |
Sep 2023 | 2023-11-02 | $-0.10 | $-0.13 | 23.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $7.32M | $10.15M | -27.9 % |
Mar 2024 | 2024-05-07 | $9.95M | $10.84M | -8.17 % |
Dec 2023 | 2024-02-20 | $9.18M | $8.88M | 3.37 % |
Sep 2023 | 2023-11-02 | $6.60M | $11.90M | -44.5 % |
AbCellera Biologics (ABCL) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.13, which beat the estimate of $-0.14.
The Actual Revenue was $7.3M, which missed the estimate of $10.2M.
Browse earnings estimates, EPS, and revenue on all stocks.